Metrion Biosciences launches NaV1.9 high-throughput screening assay to strengthen screening portfolio and advance research on new medicines for pain
Validated drug discovery assay overcomes previous challenges in targeting NaV1.9 ion channels for chronic pain signallingCompletes unique suite of rapid, scalable pain-related sodium channel assays and services to accelerate hit-to-lead and lead optimisation
BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours
Combines BioSkyrb’s new ResolveOME™ Whole Genome and Transcriptome Single-Cell Core Kit 384-well assay with Uno Single Cell Dispenser™ provided by Tecan in a single workflowEnables scalable, high-throughput analysis of hundreds to thousands of single cells, advancing ap
Mosaic Therapeutics in-licenses two clinical-stage oncology programs from Astex Pharmaceuticals for development as proprietary combination therapies
In-licensing transforms Mosaic from a research and platform company to a clinical-stage oncology business Mosaic will develop proprietary, targeted combination products, supported by proprietary biomarkers, to realise the full potential of the assets
Biodesix partner - Friends of Cancer Research, publishes study linking ctDNA changes to solid tumour treatment outcomes
Aggregate analysis of eight clinical trials of patients with advanced non-small cell lung cancer (aNSCLC) was supported by Biodesix, using Bio-Rad Droplet Digital™ PCR technology
Mursla Bio receives FDA breakthrough device designation for EvoLiver Test
Reflects the potential of EvoLiver test to improve early liver cancer detection among high-risk patients EvoLiver leverages Mursla Bio’s platform based on organ-specific extracellular vesicles circulating in blood Breakthrough status provides
Atelerix signs exclusive agreement with MineBio to establish distribution channel for non-cryogenic cell preservation solutions in China
Partnership with specialist life science distributor establishes sales channel in high-demand market and strengthens global networkHypothermic preservation technology eliminates costs and inefficiencies of cold-chain logistics to enhance biomedical research and cell the
IBL International collaborates with Grifols on advanced biomarker panels
Grifols and IBL, a Tecan company, seek to revolutionize clinical diagnostics with a future high-sensitivity, multiplexed immunoassay platform
Tecan expands portfolio for specialty diagnostics with an asset purchase relating to certain ELISA kits
Männedorf, Switzerland, April 3, 2025 – Tecan Group (SIX Swiss Exchange: TECN), announces an agreement to acquire certain assets relating to key ELISA immunoassay products from Cisbio Bioassays SAS, a subsidiary of the global life sciences and diagnostics company, Revvity In
BioTrinity 2025: Over 800 professionals convene to paint a picture of hope for UK life sciences
BioTrinity 2025 welcomed over 800 delegates, matching the highest-ever attendance set in 2024.Three action-packed tracks covered investment trends, regulatory shifts, and cutting-edge scientific advancements.Nearly 10,000 meetings requested, with 2,000
FairJourney Biologics establishes Supervisory Board
Werner Lanthaler appointed as Chair and joined by global industry leadersThe Supervisory Board will define key avenues for growth, accelerate innovation, and optimize scientific strategies to maintain leadership in antibody discovery and development
US Patent Office grants Closed Loop Medicine key patents for cardiometabolic capabilities in GLP-1 and Direct Oral Anti-Coagulants (DOAC) therapies
London, UK, 24 March 2025: Closed Loop Medicine Ltd., a leader in AI-enabled precision medicines, announces the expansion of its US patent portfolio.
Sapio Sciences makes AI-native drug discovery seamless with NVIDIA BioNeMo
Integration of the NVIDIA BioNeMo platform enhances AI capabilities across the drug discovery lifecycle
Bio-Rad launches XP-Design Assay Salmonella Serotyping Solution for rapid and accurate food safety testing
HERCULES, Calif. — 10 March Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostics products, announces the launch of XP-Design Assay Salmonella Serotyping Solution designed for the rapid detection and precise characterization of
H.E.L Group signs research agreement with the Institute of Chemical Technology (ICT) in Mumbai
Collaboration with ICT Mumbai will focus on advancing process safety and chemical synthesis in India
Shift Bioscience announces key appointments to advance rejuvenation therapeutics pipeline
Jill Reckless (CEO, RxCelerate) appointed as Translation Advisor Laurence Reid joins as Non-Executive Director, previously Decibel Therapeutics, Warp Drive Bio, Alnylam, and Millennium PharmaceuticalsCambridge, UK, 12 March 2025:&
OBN invites life science R&D companies, industry leaders, academics, and investors to BioTrinity 2025
Opening keynote from Tim Haines, Executive Partner at Abingworth, to provide a review of the life science investment landscapeExpected to welcome c900 delegates [SB1] spanning early-stage life science R&D,
TRIMTECH Therapeutics raises $31M seed funding to advance targeted protein degradation pipeline for treatment of neurodegenerative diseases
Oversubscribed financing led by Cambridge Innovation Capital and SV Health Investors’ Dementia Discovery Fund with M Ventures and Pfizer Ventures joining Investment will support further development of CNS penetrant therapeutics based on the Company’s TRIMTACTM
Centauri Therapeutics selects first clinical candidate, for immunotherapeutic treatment of Gram-negative bacterial infections
Lead candidate in the ABX-01 programme to progress into first-in-human clinical studies Programme designed to treat Gram-negative bacterial lung infections in the most vulnerable patientsLondon, UK, 4 March 2025: Centauri Therapeu
FairJourney Biologics acquires Charles River Laboratories South San Francisco facility
Acquisition of Charles River site, previously Distributed Bio, strengthens antibody discovery capabilities with SuperHuman libraries and Yeast Display platformEstablished presence in major North American biotechnology cluster extends FairJourney’s global reach
Sapio Sciences expands leadership team to drive growth
Mike Hampton Joins as Chief Commercial Officer, and New Scientific Office Strengthens Sapio’s AI-Driven Lab Informatics Leadership
Shift Bioscience establishes North American facilities to expand capabilities of AI-powered virtual cell technology
Head of Machine Learning, Lucas Camillo, to lead team with Professor Bo Wang, University of Toronto, appointed as Senior AdvisorExpansion into global AI hub to accelerate growth of IP portfolio and progress toward key technical milestones
Antibodies.com and Cactus Communications partner to accelerate life science manuscript publication
Partnership provides Antibodies.com’s network of scientists with access to CACTUS’ editorial and publishing services to improve manuscript quality and increase publication success
Gyros Protein Technologies introduces Gyrolab HEK293 HCP Type SN and Type CL Kit Reagents to support biotherapeutic development
Ready-to-use kits expand portfolio of host cell protein impurity kits, for quantification of host cell proteins from HEK293 cell lines Kits developed through a collaboration with BioGenes GmbHUppsala, Sweden, 05 February 2025:
Sapio Sciences selected by LabConnect to transform laboratory operations
Sapio LIMS to enhance research workflows, improve data integrity, and support scalable innovation
Trilobio introduces whole-laboratory automation platform at SLAS2025
· First public demonstration of unified robotics, device and software platform to be showcased at SLAS2025, 25-29 January, in San Diego, CA. Booth 2115